3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Fusobacterium nucleatum-triggered neutrophil extracellular traps facilitate colorectal carcinoma progression

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Fusobacterium nucleatum ( Fn) acts as a procarcinogenic bacterium in colorectal carcinoma (CRC) by regulating the inflammatory tumor microenvironment (TME). Neutrophil extracellular traps (NETs), which can be generated by persistent inflammation, have been recently considered to be significant contributors in promoting cancer progression. However, whether NETs are implicated in Fn-related carcinogenesis is still poorly characterized. Here, we explored the role of NETs in Fn-related CRC as well as their potential clinical significance.

          Methods

          Fn was measured in tissue specimens and feces samples from CRC patients. The expression of NET markers were also detected in tissue specimens, freshly isolated neutrophils and blood serum from CRC patients, and the correlation of circulating NETs levels with Fn was evaluated. Cell-based experiments were conducted to investigate the mechanism by which Fn modulates NETs formation. In addition, we clarified the functional mechanism of Fn-induced NETs on the growth and metastasis of CRC in vitro and in vivo experiments.

          Results

          Tissue and blood samples from CRC patients, particularly those from Fn-infected CRC patients, exhibited greater neutrophil infiltration and higher NETs levels. Fn infection induced abundant NETs production in in vitro studies. Subsequently, we demonstrated that Fn-induced NETs indirectly accelerated malignant tumor growth through angiopoiesis, and facilitated tumor metastasis, as manifested by epithelial-mesenchymal transition (EMT)-related cell migration, matrix metalloproteinase (MMP)-mediated basement membrane protein degradation, and trapping of CRC cells. Mechanistically, the Toll-like receptor (TLR4)-reactive oxygen species (ROS) signaling pathway and NOD-like receptor (NOD1/2)-dependent signaling were responsible for Fn-stimulated NETs formation. More importantly, circulating NETs combined with carcinoembryonic antigen (CEA) could predict CRC occurrence and metastasis, with areas under the ROC curves (AUCs) of 0.92 and 0.85, respectively.

          Conclusions

          Our findings indicated that Fn-induced NETs abundance by activating TLR4-ROS and NOD1/2 signalings in neutrophils facilitated CRC progression. The combination of circulating NETs and CEA was identified as a novel screening strategy for predicting CRC occurrence and metastasis.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13046-023-02817-8.

          Related collections

          Most cited references55

          • Record: found
          • Abstract: found
          • Article: not found

          Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

          This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%), followed by lung (11.4%), colorectal (10.0 %), prostate (7.3%), and stomach (5.6%) cancers. Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancers. Overall incidence was from 2-fold to 3-fold higher in transitioned versus transitioning countries for both sexes, whereas mortality varied <2-fold for men and little for women. Death rates for female breast and cervical cancers, however, were considerably higher in transitioning versus transitioned countries (15.0 vs 12.8 per 100,000 and 12.4 vs 5.2 per 100,000, respectively). The global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020, with a larger increase in transitioning (64% to 95%) versus transitioned (32% to 56%) countries due to demographic changes, although this may be further exacerbated by increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for the dissemination of cancer prevention measures and provision of cancer care in transitioning countries is critical for global cancer control.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Colorectal cancer

            Several decades ago, colorectal cancer was infrequently diagnosed. Nowadays, it is the world's fourth most deadly cancer with almost 900 000 deaths annually. Besides an ageing population and dietary habits of high-income countries, unfavourable risk factors such as obesity, lack of physical exercise, and smoking increase the risk of colorectal cancer. Advancements in pathophysiological understanding have increased the array of treatment options for local and advanced disease leading to individual treatment plans. Treatments include endoscopic and surgical local excision, downstaging preoperative radiotherapy and systemic therapy, extensive surgery for locoregional and metastatic disease, local ablative therapies for metastases, and palliative chemotherapy, targeted therapy, and immunotherapy. Although these new treatment options have doubled overall survival for advanced disease to 3 years, survival is still best for those with non-metastasised disease. As the disease only becomes symptomatic at an advanced stage, worldwide organised screening programmes are being implemented, which aim to increase early detection and reduce morbidity and mortality from colorectal cancer.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Neutrophil extracellular traps in immunity and disease

              Neutrophils are innate immune phagocytes that have a central role in immune defence. Our understanding of the role of neutrophils in pathogen clearance, immune regulation and disease pathology has advanced dramatically in recent years. Web-like chromatin structures known as neutrophil extracellular traps (NETs) have been at the forefront of this renewed interest in neutrophil biology. The identification of molecules that modulate the release of NETs has helped to refine our view of the role of NETs in immune protection, inflammatory and autoimmune diseases and cancer. Here, I discuss the key findings and concepts that have thus far shaped the field of NET biology.
                Bookmark

                Author and article information

                Contributors
                2020111361@stu.cqmu.edu.cn
                2022110332@stu.cqmu.edu.cn
                2021110568@stu.cqmu.edu.cn
                304183@hospital.cqmu.edu.cn
                2019222254@stu.cqmu.edu.cn
                yuqingzhao@stu.cqmu.edu.cn
                shueli@cqmu.edu.cn
                wurui@cqmu.edu.cn
                zhangjianbo@hospital.cqmu.edu.cn
                zhoulan@cqmu.edu.cn
                duanliang@cqmu.edu.cn
                Journal
                J Exp Clin Cancer Res
                J Exp Clin Cancer Res
                Journal of Experimental & Clinical Cancer Research : CR
                BioMed Central (London )
                0392-9078
                1756-9966
                9 September 2023
                9 September 2023
                2023
                : 42
                : 236
                Affiliations
                [1 ]GRID grid.203458.8, ISNI 0000 0000 8653 0555, Department of Laboratory Medicine, Key Laboratory of Laboratory Medical Diagnostics, Ministry of Education, , Chongqing Medical University, ; No. 1 of Yixueyuan Road, Yuzhong District, Chongqing, 400016 China
                [2 ]GRID grid.412461.4, ISNI 0000 0004 9334 6536, Department of Laboratory Medicine, , The Second Affiliated Hospital of Chongqing Medical University, ; No.74 Linjiang Road, Yu Zhong District, Chongqing, 400010 China
                [3 ]GRID grid.412461.4, ISNI 0000 0004 9334 6536, Department of Pathology, , The Second Affiliated Hospital of Chongqing Medical University, ; Chongqing, 400010 China
                [4 ]GRID grid.412461.4, ISNI 0000 0004 9334 6536, Department of Academic Research, , The Second Affiliated Hospital of Chongqing Medical University, ; Chongqing, 400010 China
                [5 ]GRID grid.203458.8, ISNI 0000 0000 8653 0555, Department of Laboratory Medicine, , The First Affiliated Hospital of Chonqing Medical University, ; Chongqing, 400016 China
                [6 ]GRID grid.412461.4, ISNI 0000 0004 9334 6536, Department of Gastrointestinal Surgery, , The Second Affiliated Hospital of Chongqing Medical University, ; Chongqing, China
                Author information
                http://orcid.org/0000-0002-3882-7527
                Article
                2817
                10.1186/s13046-023-02817-8
                10492297
                37684625
                4e45de32-89ef-4235-bfb4-acb679dfc179
                © Italian National Cancer Institute ‘Regina Elena’ 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 8 May 2023
                : 29 August 2023
                Funding
                Funded by: the National Natural Science Foundation of China
                Award ID: 82072364
                Award ID: 82002152
                Award Recipient :
                Funded by: Natural Science Foundation of Chongqing
                Award ID: CSTB2023NSCQMSX0037
                Award Recipient :
                Funded by: Senior Medical Talents Program of Chongqing for Young and Middle-aged
                Award ID: 2022-15
                Award Recipient :
                Categories
                Research
                Custom metadata
                © Italian National Cancer Institute ‘Regina Elena’ 2023

                Oncology & Radiotherapy
                fusobacterium nucleatum,colorectal carcinoma,neutrophil extracellular traps,ros,tlr4,nod1/2

                Comments

                Comment on this article